Literature DB >> 7139897

Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.

H S Karagueuzian, T Fujimoto, T Katoh, T Peter, A McCullen, W J Mandel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7139897     DOI： 10.1161/01.cir.66.6.1190

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Tissue distribution of propafenone in the rat after intravenous administration.

Authors:  J Fernández; L Lligoña; A Puigdemont; R Guitart; J L Riu; M Arboix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

2.  Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles.

Authors:  Young Soo Lee; Mitsunori Maruyama; Po Cheng Chang; Hyung Wook Park; Kyoung-Suk Rhee; Yu-Cheng Hsieh; Chia-Hsiang Hsueh; Changyu Shen; Shien-Fong Lin; Hyun Seok Hwang; Huiyong Yin; Björn C Knollmann; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 3.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

4.  Functional and metabolic effects of propafenone in the rat heart-lung preparation.

Authors:  S Kashimoto; T Oguchi; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

5.  Effects of propafenone on calcium current in guinea-pig ventricular myocytes.

Authors:  C Delgado; J Tamargo; D Henzel; P Lorente
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Effects of propafenone on function and metabolism in the ischemic working rat heart.

Authors:  T Nakamura; S Kashimoto; T Oguchi; T Kumazawa
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

7.  Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.

Authors:  K Hashimoto; M Ishii; S Komori; H Mitsuhashi
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

8.  Propafenone for the treatment of severe ventricular arrhythmias.

Authors:  S W Rabkin; C E Rotem; K Boroomand-Rashti; B Bar-Shlomo
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

9.  Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.

Authors:  C Delgado; J Tamargo; T Tejerina
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.